Last reviewed · How we verify
Treatment and Duration Effect of Pentosan Polysulfate Sodium (PPS) in Participants With Knee Osteoarthritis Pain
The purpose of this study is to measure the duration of treatment effect with subcutaneous injections of pentosan polysulfate sodium (PPS) compared with placebo in adult participants with knee osteoarthritis (OA) pain. The study duration will be up to 34 weeks. Participants who completed pDay 162 of Study PARA\_OA\_002 (i.e. did not discontinue/withdraw prematurely from the parent study) will be invited to participate.
Details
| Lead sponsor | Paradigm Biopharmaceuticals Ltd. |
|---|---|
| Status | COMPLETED |
| Enrolment | 133 |
| Start date | Sat Jun 24 2023 00:00:00 GMT+0000 (Coordinated Universal Time) |
| Completion | Tue Dec 24 2024 00:00:00 GMT+0000 (Coordinated Universal Time) |
Conditions
- Osteoarthritis, Knee
Interventions
- Pentosan Polysulphate Sodium
- Placebo (Sodium Chloride Injection, 0.9%)
Countries
United States, Australia